BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Business

  Fueled by Growth, Alcami Unveils New Sales Office in Cambridge, MA

  The Kendall Square facility will support robust customer growth and connect Alcami to the forefront of hundreds of thriving pharma and biotech start-ups and innovators.

  February 13, 2018

   · 

  2 min read
• Policy

  FDA Permits Marketing of Clinical Decision Support Software for Alerting Providers of a Potential Stroke in Patients

  A stroke is a serious medical condition that requires emergency care and can cause lasting brain damage, long-term disability or even death.

  February 13, 2018

   · 

  4 min read
• Business

  Neurocrine Biosciences Reports Fourth Quarter and Year-End 2017 Financial Results and Provides Investor Update for 2018

  Neurocrine Biosciences today announced its financial results for the fourth quarter and year-end of 2017, and provided an update on the launch of INGREZZA and clinical development programs for 2018.

  February 13, 2018

   · 

  20 min read
• Business

  Bionik Laboratories Reports Third Quarter Fiscal Year 2018 Financial Results

  Bionik today announced its third quarter fiscal year 2018 financial results for the three and nine months ended December 31, 2017.

  February 13, 2018

   · 

  24 min read
• Business

  Myovant Sciences Provides Corporate Update and Reports Financial Results for Third Fiscal Quarter Ended December 31, 2017

  Positive results in two Phase 3 clinical studies conducted by Takeda to evaluate the efficacy and safety of relugolix for the treatment of uterine fibroids.

  February 13, 2018

   · 

  17 min read
• Business

  Jazz Pharma to Report 2017 Fourth Quarter and Full Year Financial Results on February 27, 2018

  Jazz Pharma today announced that it will report its 2017 fourth quarter and full year financial results on Tuesday, February 27, 2018, after the close of the financial markets.

  February 13, 2018

   · 

  2 min read
• 

  Biotech Beach

  Tandem Diabetes Care Closes $69M Underwritten Public Offering of Common Stock

  Oppenheimer & Co. Inc. acted as the sole book-running manager for the offering.

  February 13, 2018

   · 

  2 min read
• Pharm Country

  Synergy Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

  Synergy today announced that the Compensation Committee of the Board of Directors of Synergy approved the grant of inducement stock options to purchase 289,000 shares of Synergy common stock to 193 former contract sales representatives

  February 13, 2018

   · 

  3 min read
• Genetown

  Ra Pharmaceuticals Announces Proposed Public Offering of Common Stock

  Ra Pharma today announced that it intends to offer and sell, subject to market and other conditions, $50 million of its common stock in an underwritten public offering.

  February 13, 2018

   · 

  3 min read
• 

  Business

  Presbia Names a New COO, Effective Immediately

  As COO, Ms. Lind is responsible for the Company’s manufacturing, engineering, quality and IT departments.

  February 13, 2018

   · 

  3 min read